98273-15-5

Upstream product

• 91448-08-7 3-Hydroxy-4-carboxy-benzoldiazonium-chlorid 
• 7758-89-6 copper(I) chloride 
• 6018-19-5 sodium p-aminosalicylate dihydrate 

Downstream Products

• 134360-33-1 CGP 46251 
• 192052-77-0 Ac-Glu(O^tBu)-Tyr[SO₂C₆H₃(3-OH)(4-COOH)]-Leu-Arg(Pmc)-NH₂ 
• 250608-93-6 4-[4-(9-Bromo-2,3-dimethyl-naphtho[2,3-b]thiophen-4-yl)-2-isopropyl-phenoxysulfonyl]-2-hydroxy-benzoic acid 
• 250608-94-7 4-[4-(9-bromo-2,3-dimethyl-naphtho[2,3-b]thiophen-4-yl)-2,6-dimethyl-phenoxysulfonyl]-2-hydroxy-benzoic acid 

Relevant academic research and scientific papers

Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia

This invention provides compounds of Formula I having the structure: wherein R1, R2, R3, R4, R5, R6, R7, R8, W, X, Y, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

Naphtho[2,3-B]heteroar-4-yl derivatives

This invention provides compounds of Formula I having the structure wherein R1, R2, R3, R4, R5, W, R9, X, R6, p, Y, Z, R7, and R8 are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.